The metabolic versatility of Xenorhabdus and Photorhabdus underscores their ecological significance and untapped potential as sources of novel bioactive natural products.
Abstract
Xenorhabdus and Photorhabdus are Gram-negative entomopathogenic bacteria (EPB) that form mutualistic associations with nematodes and play a central role in insect pathogenesis. These bacteria are prolific producers of secondary metabolites, which exhibit remarkable structural diversity and a wide range of biological functions. The various secondary metabolites produced by these genera include peptides, lipopeptides, polyketides, hybrid non-ribosomal peptide synthase-polyketide synthase (NRPS-PKS) compounds, phenolic compounds, indole derivatives, stilbenes and other unique scaffolds. These compounds demonstrate potent antimicrobial, antifungal, cytotoxic, immunosuppressive, antiparasitic and insecticidal properties, which are crucial not only for suppressing insect host immunity and facilitating nematode reproduction but also for outcompeting other microorganisms within the insect cadaver. The biosynthesis of these metabolites is governed by complex gene clusters, often involving modular non-ribosomal peptide synthetases and polyketide synthases that are tightly regulated by global and pathway-specific mechanisms. Despite significant progress, many biosynthetic pathways remain uncharacterised, underscoring the need for more comprehensive genomic, transcriptomic and metabolomic investigations. Future research involving genome mining, synthetic biology and heterologous expression hold promise for the discovery of novel bioactive compounds. Given their potent biological activities, these metabolites have strong potential in applied sciences, including their use as environmentally friendly insecticides in agricultural biocontrol and as new antibiotics or immunomodulatory agents in pharmaceutical development. Overall, the metabolic versatility of Xenorhabdus and Photorhabdus underscores their ecological significance and untapped potential as sources of novel bioactive natural products.
An integrative perspective on Microbispora as an underexplored but promising source of structurally diverse and bioactive natural products for drug discovery is provided.
This review systematically summarizes 226 secondary metabolites reported from I. lacteus, covering their chemical classification, biosynthetic features, biotransformation capabilities, and biological activities, and the potential applications of I. lacteus metabolites in agriculture, food chemistry, and sustainable bio...
A spore-free, high-yield, scalable production platform for oosporein was established, highlighting the potential of rare, protected fungal species as sources for valuable enzymes and bioactive secondary metabolites for efficient microbial biomanufacturing systems.
Niklas Broel, F. V. Wengner, J. Stein et al.· Journal of Agricultural and...· 0 citations
Unlike the antimicrobial darobactin, aphotorhaptin A appears to lack antibacterial activity but modulates nematode development, and this activity requires the ether crosslink and the N-terminal acetyl group in the hexapeptide scaffold.
Suze Ma, Ru Li, Xiang-Yang Gao et al.· Proceedings of the National...· 0 citations
This study demonstrates that Bacillus velezensis SPE2, a low-abundance isolate from the phycosphere of dinoflagellate, exhibits a wide degree of antagonistic activity against multiple marine Flavobacteriaceae strains, a dominant taxonomic group across the phycosphere of diverse phytoplankton species.
Runlin Cai, Hao Feng, Yang Liu et al.· Environmental Microbiome· 0 citations
Highly diversified specialized metabolism enables plant communication with pollinators, herbivores, and protectors1–4. Its chemodiversity, under which evenness, richness and variation is summarized5–7, includes many compounds without known function1–4 and presents an evolutionary conundrum about how and what is selecte...
Marvin Hildebrandt, Bianca Laker, D. Ziaja et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.